Literature DB >> 22888389

A 72-year-old man with duodenal adenocarcinoma.

Sally Tamraz, Ali Shamseddine, Manish Shah, Mohamed El-Oubeidi, Ghazi Zaatari, Fady Geara, Maeve A Lowery, Eileen M O'Reilly, Aghiad Al-Kutoubi, Walid Faraj, David P Kelsen, Ghassan K Abou-Alfa.   

Abstract

Entities:  

Year:  2012        PMID: 22888389      PMCID: PMC3415721     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN: 1934-7820


× No keyword cloud information.
  12 in total

1.  The American College of Surgeons Commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995.

Authors:  J R Howe; L H Karnell; H R Menck; C Scott-Conner
Journal:  Cancer       Date:  1999-12-15       Impact factor: 6.860

2.  Mutations of the Ki-ras, p53 and APC genes in adenocarcinomas of the human small intestine.

Authors:  M Arai; S Shimizu; Y Imai; Y Nakatsuru; H Oda; T Oohara; T Ishikawa
Journal:  Int J Cancer       Date:  1997-02-07       Impact factor: 7.396

3.  Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum.

Authors:  Michael J Swartz; Michael A Hughes; Deborah A Frassica; Joseph Herman; Charles J Yeo; Taylor S Riall; Keith D Lillemoe; John L Cameron; Ross C Donehower; Daniel A Laheru; Ralph H Hruban; Ross A Abrams
Journal:  Arch Surg       Date:  2007-03

4.  Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Authors:  J S Macdonald; S R Smalley; J Benedetti; S A Hundahl; N C Estes; G N Stemmermann; D G Haller; J A Ajani; L L Gunderson; J M Jessup; J A Martenson
Journal:  N Engl J Med       Date:  2001-09-06       Impact factor: 91.245

5.  A single-institution experience with 491 cases of small bowel adenocarcinoma.

Authors:  Thorvardur R Halfdanarson; Robert R McWilliams; John H Donohue; J Fernando Quevedo
Journal:  Am J Surg       Date:  2010-06       Impact factor: 2.565

Review 6.  Primary adenocarcinoma of the duodenum.

Authors:  I A Spira; A Ghazi; W I Wolff
Journal:  Cancer       Date:  1977-04       Impact factor: 6.860

7.  Molecular analysis of PIK3CA, BRAF, and RAS oncogenes in periampullary and ampullary adenomas and carcinomas.

Authors:  Frank Schönleben; Wanglong Qiu; John D Allendorf; John A Chabot; Helen E Remotti; Gloria H Su
Journal:  J Gastrointest Surg       Date:  2009-05-14       Impact factor: 3.452

8.  Primary carcinoma of the duodenum.

Authors:  A Alwmark; A Andersson; A Lasson
Journal:  Ann Surg       Date:  1980-01       Impact factor: 12.969

9.  Non-ampullary duodenal adenocarcinoma: factors important for relapse and survival.

Authors:  Aaron Struck; Thomas Howard; Elena G Chiorean; Jeffrey M Clarke; Robert Riffenburgh; Higinia R Cardenes
Journal:  J Surg Oncol       Date:  2009-08-01       Impact factor: 3.454

Review 10.  Adjuvant chemotherapy for small intestine adenocarcinoma.

Authors:  N Singhal; D Singhal
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.